1. Home
  2. ARWR vs DV Comparison

ARWR vs DV Comparison

Compare ARWR & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

N/A

Current Price

$64.39

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

N/A

Current Price

$11.39

Market Cap

1.9B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ARWR
DV
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
1.9B
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
ARWR
DV
Price
$64.39
$11.39
Analyst Decision
Strong Buy
Buy
Analyst Count
10
17
Target Price
$63.70
$16.56
AVG Volume (30 Days)
3.3M
2.2M
Earning Date
11-25-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$829,448,000.00
$733,324,000.00
Revenue This Year
N/A
$17.93
Revenue Next Year
N/A
$10.74
P/E Ratio
N/A
$42.78
Revenue Growth
23258.15
14.86
52 Week Low
$9.57
$7.64
52 Week High
$72.36
$23.11

Technical Indicators

Market Signals
Indicator
ARWR
DV
Relative Strength Index (RSI) 62.85 58.62
Support Level $59.51 $10.67
Resistance Level $72.36 $11.26
Average True Range (ATR) 4.67 0.31
MACD -0.11 0.08
Stochastic Oscillator 59.17 74.22

Price Performance

Historical Comparison
ARWR
DV

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: